Janney Montgomery Scott LLC Eagle Pharmaceuticals, Inc. Transaction History

Janney Montgomery Scott LLC

  • $35.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 01, 2019
SELL
$36.72 - $67.73 $171,151 - $315,689
-4,661 Closed
0 $0
Q3 2018

Nov 05, 2018
BUY
$66.65 - $83.86 $310,655 - $390,871
4,661 New
4,661 $323,000
Q2 2018

Jul 24, 2018
SELL
$51.25 - $76.62 $634,270 - $948,249
-12,376 Closed
0 $0
Q1 2018

Apr 19, 2018
BUY
$52.16 - $66.86 $645,532 - $827,459
12,376 New
12,376 $652,000

Others Institutions Holding EGRX

# of Institutions
70
Shares Held
8.6M
Call Options Held
1M
Put Options Held
100
View Full List

About EAGLE PHARMACEUTICALS, INC.

EGRX Quotes by TradingView
  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email